Bi-ventricular assist
This article was originally published in The Gray Sheet
Executive Summary
Biophan Technologies will direct the development, regulatory approval and marketing of Myotech's Myo-Vad minimally invasive bi-ventricular assist device. Myo-Vad is based on Myotech's Direct Mechanical Ventricular Assist (DMVA) technology - a flexible polymer cup installed around the heart through a small incision in about three minutes. The cup, featuring a pneumatically activated liner connected to a control line, compresses and expands to support both ventricles of the heart. The technology has been tested in over 700 animals...